A tradition of innovation
EDAP TMS history and innovations in prostate cancer and urinary tract stones treatments.
Since it was founded in 1979, EDAP TMS has been committed to introducing new and innovative technologies for a minimally-invasive approach to treating urological disorders.
These proprietary technologies such as Focused Ultrasound or Piezo-electric shock waves have yielded new minimally invasive procedures for the treatment of several pathologies such as benign prostatic hyperplasia, localized prostate cancer or urinary tract stones.
EDAP TMS' design philosophy is to develop minimally-invasive devices for the benefit of the patient associating treatment efficacy and safety. The strength of EDAP TMS' R&D is to master mechanical, acoustic, electronic and IT technologies to produce state-of-the-art and ergonomic medical devices.
EDAP TMS's products are alternatives to traditional surgical procedures which often involve high cost, significant side effects and long recovery times.
Founded in 1979, the Company originally specialized in the manufacturing and distribution of ultrasound scanners and produced the first piezo-electric lithotripter in 1985. In 1994, the Company purchased most of the assets of Technomed International S.A. ("Technomed''). Technomed was established in 1985 and launched an electrohydraulic lithotripter in 1986 and the Prostatron, a medical device using TUMT (Transurethral Microwave Therapy) for the minimally-invasive treatment of Benign Prostate Hyperplasia (BPH), a non-cancerous urological condition.
|ESWL innovations and patents|
Piezo-electric lithotripsy with in-line sonography (LT01).
|1985||Cooperation between EDAP TMS and the INSERM (French Institute of Medical Research) leading to the development of the Sonolith® 2000 equipped with a conventional electrohydraulic generator.|
|1986||First ultrasound imaging navigator for ESWL (ultrasound imaging arm) on the Sonolith® 2000.|
|1990||Sonolith® hydrophone patent covering pressure regulation technology on ESWL shock-wave generators.|
|1994||EDAP TMS and INSERM jointly develop the patented Electroconductive technology for Sonolith® lithotripters.|
|TUMT innovations and patents|
|1988||Prostatron patent to use microwaves and urethral cooling for BPH treatment.|
|1990||EDAP TMS develops the Prostatron using the microwave technology for the treatment of BPH. The Prostatron received CE mark and FDA approval.|
|HIFU innovations and patents|
|1989||EDAP TMS and INSERM jointly develop HIFU technology|
|1991||Patent on Ablahterm® transducer design covering geometry and materials.|
|1993||Ablatherm® HIFU is used for the first prostate cancer treatments on men (prototype device).|
|1994||Patent covering rectal wall monitoring function patent.|
|1996||The first multicenter study on Ablatherm® HIFU is launched.|
|1999||Ablasonic® fluid patent.|
|1999-2000||Ablatherm® HIFU receives the CE mark and industrial production starts.|
|2000||Ablapak® disposable kit patent.|
Ablatherm® HIFU Integrated Imaging is launched. The probe integrates both the imaging and the treatment tranducers.
Integrated Imaging patent for the dual transducer Ablatherm® probe.